Focused Wealth Management, Inc Prothena Corp Public LTD CO Transaction History

Focused Wealth Management, Inc

$820 Million
Q2 2025

A detailed history of Focused Wealth Management, Inc transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Focused Wealth Management, Inc holds 32,129 shares of PRTA stock, worth $247,072. This represents 0.02% of its overall portfolio holdings.

Number of Shares

32,129

Previous 32,129 -0.0%

Holding current value

$247,072

Previous $397,000 50.88%

% of portfolio

0.02%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 28, 2025	BUY	$11.95 - $18.35 $383,941 - $589,567	32,129 New	32,129 $444,000
Q2 2024 Jul 30, 2024	BUY	$19.54 - $26.15 $195,400 - $261,500	10,000 Added 98.73%	20,129 $415,000
Q1 2024 May 08, 2024	BUY	$24.75 - $40.66 $247,500 - $406,599	10,000 Added 7751.94%	10,129 $250,000
Q1 2022 Apr 29, 2022	SELL	$30.27 - $49.22 $68,501 - $111,384	-2,263 Reduced 94.61%	129 $5,000
Q3 2021 Oct 12, 2021	SELL	$48.2 - $78.89 $109,028 - $178,449	-2,262 Reduced 48.6%	2,392 $170,000
Q2 2021 Jul 15, 2021	SELL	$21.63 - $57.65 $97,875 - $260,866	-4,525 Reduced 49.3%	4,654 $239,000
Q1 2021 May 03, 2021	SELL	$11.0 - $28.24 $35,002 - $89,859	-3,182 Reduced 25.74%	9,179 $231,000
Q4 2020 Feb 03, 2021	SELL	$10.12 - $13.94 $73,845 - $101,720	-7,297 Reduced 37.12%	12,361 $148,000
Q3 2020 Oct 19, 2020	BUY	$9.93 - $13.47 $15,798 - $21,430	1,591 Added 8.81%	19,658 $196,000
Q1 2020 May 06, 2020	BUY	$7.54 - $15.77 $11,996 - $25,090	1,591 Added 9.66%	18,067 $193,000
Q4 2019 Jan 21, 2020	BUY	$7.48 - $17.01 $21,692 - $49,329	2,900 Added 21.36%	16,476 $261,000
Q3 2019 Nov 06, 2019	BUY	$6.89 - $10.45 $21,703 - $32,917	3,150 Added 30.21%	13,576 $106,000
Q3 2018 Nov 13, 2018	BUY	$12.7 - $15.79 $368 - $457	29 Added 0.28%	10,426 $136,000
Q2 2018 Aug 15, 2018	BUY	$10.99 - $44.21 $35,684 - $143,549	3,247 Added 45.41%	10,397 $152,000
Q1 2018 May 07, 2018	BUY	$27.95 - $45.04 $27,950 - $45,040	1,000 Added 16.26%	7,150 $262,000
Q4 2017 Feb 13, 2018	SELL	$35.44 - $63.76 $109,864 - $197,656	-3,100 Reduced 33.51%	6,150 $231,000
Q3 2017 Nov 14, 2017	BUY	$53.83 - $67.75 $107,660 - $135,500	2,000 Added 27.59%	9,250 $599,000
Q2 2017 Aug 14, 2017	BUY	N/A	7,250	7,250 $392,000

Others Institutions Holding PRTA

# of Institutions

192

Shares Held

44.9M

Call Options Held

251K

Put Options Held

79.2K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $361M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Focused Wealth Management, Inc with notifications on news.

Account

Focused Wealth Management, Inc Prothena Corp Public LTD CO Transaction History